ANTIMICROBIALAGENTSANDCHEMOTHERAPY,Dec.2003,p.3750–37590066-4804/03/$08.00 0DOI:10.1128/AAC.47.12.3750–3759.2003
Copyright©2003,AmericanSocietyforMicrobiology.AllRightsReserved.
Vol.47,No.12
InVitroandInVivoAntibacterialActivitiesofDK-507k,a
NovelFluoroquinolone
TsuyoshiOtani,*MayumiTanaka,EmiIto,YuichiKurosaka,YoichiMurakami,
KiyomiOnodera,TakaakiAkasaka,andKenichiSato
NewProductResearchLaboratoriesI,DaiichiPharmaceuticalCo.Ltd.,Tokyo,Japan
Received21March2003/Returnedformodi cation8July2003/Accepted31August2003
TheantibacterialactivitiesofDK-507k,anovelquinolone,werecomparedwiththoseofotherquinolones:cipro oxacin,gati oxacin,levo oxacin,moxi oxacin,sita oxacin,andgarenoxacin(BMS284756).DK-507kwasasactiveassita oxacinandwasasactiveasoruptoeightfoldmoreactivethangati oxacin,moxi oxacin,andgarenoxacinagainstStreptococcuspneumoniae,methicillin-susceptibleandmethicillin-resistantStaphylo-coccusaureus,andcoagulase-negativestaphylococci.DK-507kwasasactiveasor4-foldmoreactivethangarenoxacinand2-to16-foldmoreactivethangati oxacinandmoxi oxacinagainstcipro oxacin-resistantstrainsofS.pneumoniae,includingclinicalisolatesandinvitro-selectedmutantswithknownmutations.DK-507kinhibitedallcipro oxacin-resistantstrainsofS.pneumoniaeat1 g/ml.Atime-killassaywithS.pneumoniaeshowedthatDK-507kwasmorebactericidalthangati oxacinandmoxi oxacin.TheactivitiesofDK-507kagainstmostmembersofthefamilyEnterobacteriaceaewerecomparabletothoseofcipro oxacinandequaltoorupto32-foldhigherthanthoseofgati oxacin,levo oxacin,moxi oxacin,andgarenoxacin.DK-507kwasfourfoldlessactivethansita oxacinandcipro oxacinagainstPseudomonasaeruginosa,whileitwastwotofourtimesmorepotentthanlevo oxacin,gati oxacin,moxi oxacin,andgarenoxacinagainstP.aeruginosa.Invivo,intravenoustreatmentwithDK-507kwasmoreeffectivethanthatwithgati oxacinandmoxi oxacinagainstsystemicinfectionscausedbyS.aureus,S.pneumoniae,andP.aeruginosainmice.Inamousemodelofpneumoniaduetopenicillin-resistantS.pneumoniae,DK-507kadministeredsubcutaneouslyshoweddose-dependentef cacyandeliminatedthebacteriafromthelungs,whereasgati oxacinandmoxi- oxacinhadnosigni cantef cacy.OraltreatmentwithDK-507kwasslightlymoreeffectivethanthatwithcipro oxacininaratmodelofforeignbody-associatedurinarytractinfectioncausedbyaP.aeruginosaisolateforwhichtheMICofDK-507kwasfourfoldhigherthanthatofcipro oxacin.OraladministrationofDK-507ktoratsachievedhigherpeakconcentrationsinserumandhigherconcentrationsincumulativeurinethanthoseachievedwithcipro oxacin.ThesedataindicatethepotentialadvantagesofDK-507koverotherquinolonesforthetreatmentofawiderangeofcommunity-acquiredinfections.
Ascommunity-acquiredpathogensareexhibitingincreasinglevelsofresistanceto -lactamsandmacrolides,quinoloneshaveemergedasoneofthe rst-linedrugsfortherapyforrespiratoryinfectionsandurinarytractinfectionsinthecom-munity(3,4,24).
Theapplicationofnewerquinolones,suchaslevo oxacin,gati oxacin,andmoxi oxacin,withenhancedpotenciesagainstgram-positivebacteriaforthetreatmentofcommunity-acquiredrespiratoryinfectionshasbecomeimportantbecauseoftheworldwideprevalenceofpenicillin-andmultidrug-resis-tantStreptococcuspneumoniaestrains(1,10,14,21,22).How-ever,eventhesenewerquinoloneshaverelativelyhighMICsthatmaylimittheirtherapeuticvalueagainstsomestrainsofcipro oxacin-resistantpneumococciforwhichtheMICsareclosetoorabovethebreakpoint(6,11,19,26).Ontheotherhand,community-acquiredurinarytractinfectionsareamongthemostcommonlyobservedinfectionsinclinicalpractice.Quinoloneshaveprimarilybeenusedfortherapyforpatientswithurinarytractinfections,inwhichgram-negativebacteriaarethemostcommoncausativeagents(8,16).Recenttrends,
however,oftheapplicationofquinolonesforthetreatmentofrespiratorytractinfectionsbyimprovingtheirantibacterialac-tivitiesagainstgram-positivebacteriaarelikelyassociatedwitharelativedecreaseinactivityagainstgram-negativebacteria,eveniftheactivitystillhastherapeuticvalue.Therefore,thedevelopmentofquinoloneswithpotentialutilityforthetreat-mentofinfectionscausedbybothgram-positiveandgram-negativebacteriawouldrepresentsigni cantprogress.
DK-507kisanovel uoroquinolonewiththechemicalstruc-tureshowninFig.1(K.Kawakamietal.,Abstr.41stIntersci.Conf.Antimicrob.AgentsChemother.,abstr.F-546,2001).DK-507kpossessedimprovedactivityagainstgram-positivebacteria,includingsomestrainsresistanttotheavailablequin-olones,whiletheactivityofthecompoundagainstgram-neg-ativebacteriawasmaintained.ToinvestigatethepotencyofDK-507kagainstabroadspectrumofbacterialpathogens,westudieditsinvitroantibacterialactivitiesagainstavarietyofrecentclinicalisolatesanditsinvivoef cacyinmousemodelsofsepticemiacausedbyS.pneumoniae,Staphylococcusaureus,Escherichiacoli,andPseudomonasaeruginosa;amousemodelofpneumococcalpneumonia;andaratmodelofforeignbody-associatedurinarytractinfectioncausedbyP.aeruginosa.Thecomparatoragentswerecipro oxacin,gati oxacin,levo oxa-cin,moxi oxacin,sita oxacin,andgarenoxacin(BMS284756).(Thisworkwaspresentedinpartatthe41stInterscience
3750
*Correspondingauthor.Mailingaddress:NewProductResearchLaboratoriesI,DaiichiPharmaceuticalCo.Ltd.,16-13Kitakasai1-Chome,Edogawa-ku,Tokyo134-8630,Japan.Phone:81-3-5696-8378.Fax:81-3-5696-4264.E-mail:otanir16@daiichipharm.co.jp.
In vitro antibacterial a... 暂无评价 7页 免费 3750-大鼠尿路感染In ...Thus, the antibacterial activities of medicinal plants reported in the ...
c o m / l o c a t e / c b p b Antibacterial activity in vivo and in vitro in the hemolymph of Galleria mellonella infected with Pseudomonas ...
Chemical Composition and in Vitro Antibacterial Activity of the Leaf Essential Oil of Mentha off_专业资料。JCeCeEg6(02410 .hm.hm.n.21)0.94… 蟥 ...
antioxidant, antibacterial activities, in vivo and Invitro immuno modulation ... 3750-大鼠尿路感染In Vi... 暂无评价 10页 3下载券 Studies on the in ...
pilosa. Therefore, the aim of the present work was carried out to study in vitro antioxidant, antibacterial, and antifungal activities of the essential ...
the antioxidative activity of persimmon extract in vitro and in vivo. ...In addition, the in vitro antioxidant activities of MPP and its subfractions...
3750-大鼠尿路感染In Vitr... 暂无评价 10页 8财富值 The use of ... In vitro activities of aztreonamIn vitro activities of aztreonam隐藏>> AND ...
巴洛沙星片治疗急性泌尿系统感染 105 例姚钢炼,廖婷婷,桂保松 (西安交通大学...In vitro and in vivo antibacterial activities of Q-35, a novel ...
Studies on the in vitro and in vivo antiurolithic activity 隐藏>> Urol ... antioxidant and renal epithelial cell protective activities and may provide ...
containing PLGA and evaluation of anti-tumor activity in vitro and in vivo...Antimicrobial activities of some selected traditional Ethiopian medicinal plants ...
热门文档